Literature DB >> 8480892

Laparoscopic management of acute cholecystitis.

K A Zucker1, J L Flowers, R W Bailey, S M Graham, J Buell, A L Imbembo.   

Abstract

The role of laparoscopic surgery in patients presenting with acute cholecystitis remains controversial. From September 1989 through August 1992, a total of 720 patients underwent cholecystectomy. Ninety-six were unplanned admissions with a clinical diagnosis of acute cholecystitis. Laparoscopic surgery was attempted in 83 patients. Thirteen individuals were not offered laparoscopy because of the surgeon's inexperience. Twenty-two (27%) patients required the laparoscopic procedure converted to an open laparotomy. The mean postoperative hospital stay for patients undergoing laparoscopic cholecystectomy was 3.3 days versus 6.8 days for the laparotomy group. There was no mortality and no bile duct or major vascular injuries in either group. The overall operative morbidity rate was 16.9%. Laparoscopic cholecystectomy appears to be a safe and beneficial option in selected patients with acute cholecystitis. A low threshold for conversion to laparotomy appeared to be an important factor in maintaining a low incidence of operative complications. Several modifications to the technique of laparoscopic cholecystectomy have evolved over the 3-year study period and are described.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8480892     DOI: 10.1016/s0002-9610(05)80951-1

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  27 in total

1.  A simple technique for decompression of distended gallbladder during laparoscopic cholecystectomy.

Authors:  A A Saber; D Rosin; O E Brasesco; S Avital; R J Rosenthal
Journal:  Surg Endosc       Date:  2002-02-08       Impact factor: 4.584

2.  Laparoscopic cholecystectomy for acute cholecystitis: can the need for conversion and the probability of complications be predicted? A prospective study.

Authors:  A Brodsky; I Matter; E Sabo; A Cohen; J Abrahamson; S Eldar
Journal:  Surg Endosc       Date:  2000-08       Impact factor: 4.584

3.  Early versus delayed laparoscopic cholecystectomy for acute cholecystitis: a prospective randomized trial.

Authors:  S B Kolla; S Aggarwal; A Kumar; R Kumar; S Chumber; R Parshad; V Seenu
Journal:  Surg Endosc       Date:  2004-07-07       Impact factor: 4.584

Review 4.  The E.A.E.S. Consensus Development Conferences on laparoscopic cholecystectomy, appendectomy, and hernia repair. Consensus statements--September 1994. The Educational Committee of the European Association for Endoscopic Surgery.

Authors:  E Neugebauer; H Troidl; C K Kum; E Eypasch; M Miserez; A Paul
Journal:  Surg Endosc       Date:  1995-05       Impact factor: 4.584

5.  Prospective randomized study of early versus delayed laparoscopic cholecystectomy for acute cholecystitis.

Authors:  C M Lo; C L Liu; S T Fan; E C Lai; J Wong
Journal:  Ann Surg       Date:  1998-04       Impact factor: 12.969

6.  Early versus delayed laparoscopic cholecystectomy for treatment of acute cholecystitis.

Authors:  C M Lo; C L Liu; E C Lai; S T Fan; J Wong
Journal:  Ann Surg       Date:  1996-01       Impact factor: 12.969

7.  Laparoscopic subtotal cholecystectomy for severe cholecystitis.

Authors:  Jun Nakajima; Akira Sasaki; Toru Obuchi; Shigeaki Baba; Hiroyuki Nitta; Go Wakabayashi
Journal:  Surg Today       Date:  2009-09-27       Impact factor: 2.549

8.  Admission after the gold interval in acute calculous cholecystitis: Should we really cool it off?

Authors:  M A Bozkurt; M Gönenç; K D Peker; H Yırgın; H Alış
Journal:  Eur J Trauma Emerg Surg       Date:  2016-01-07       Impact factor: 3.693

9.  Laparoscopic cholecystectomy for acute cholecystitis: does timing matter?

Authors:  Baiju Senadhipan; Sreekanth S Kumar; Srikanth Damodaran Pillai
Journal:  Indian J Surg       Date:  2012-06-16       Impact factor: 0.656

10.  Male gender: risk factor for severe symptomatic cholelithiasis.

Authors:  Heng-Hui Lein; Ching-Shui Huang
Journal:  World J Surg       Date:  2002-03-01       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.